Literature DB >> 12375192

Cardiac malformations associated with the Holt-Oram syndrome--report on a family and review of the literature.

T Bossert1, T Walther, J Gummert, R Hubald, M Kostelka, F W Mohr.   

Abstract

The Holt-Oram syndrome (HOS) is characterized by mild-to-severe congenital cardiac defects and skeletal abnormalities of the upper limb. The most common cardiac disorder is an ostium secundum atrial septal defect (ASD), followed by ventricular septal defect (VSD) and ostium primum ASD. Electrocardiographic abnormalities, such as various degrees of atrioventricular block, have also been reported. In addition, hypoplastic peripheral vessels of the upper limbs have been observed. Here, we will report about a family with three sons having HOS, and we will detail the cardiac spectrum of HOS as reported in the literature.

Entities:  

Mesh:

Year:  2002        PMID: 12375192     DOI: 10.1055/s-2002-34573

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  4 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

2.  Total anomalous pulmonary venous connection : Autopsy considerations.

Authors:  Roger W Byard; John D Gilbert
Journal:  Forensic Sci Med Pathol       Date:  2005-09       Impact factor: 2.007

3.  Anaesthetic management of emergency cesarean section in a patient with holt oram syndrome.

Authors:  Babu N Girish; S Rajesh; P Somasekharam; Pradeep Kumar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2010-10

4.  Familial clustering of congenital deafness, patent ductus arteriosus, Eisenmenger complex, and differential cyanosis: A case report.

Authors:  Ting-Wei Lin; Chih-Wei Tseng; Chi-Yao Huang; Kuo-Yang Wang; Kae-Woei Liang
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.